The incidence of breastfeeding among women with insulin dependent diabetes mellitus (IDDM) has received little attention. During a 17-month period, 19 pregnant women with IDDM attending the prenatal clinic of the Royal Women's Hospital (Brisbane) were recruited into a prospective study to compare their breastfeeding outcomes with a control group of 18 women who were not diabetic (non-IDDM). The incidence of breastfeeding was monitored. At discharge, 63 percent of IDDM and 78 percent of non-IDDM mothers were breastfeeding. At eight weeks, the proportion of each were nearly identical (58 percent and 56 percent respectively), and at three months of age, 47 percent of IDDM mothers and 33 percent of non-IDDM women continued to breastfeed. We conclude that women with IDDM breastfeed at least as commonly and for as long as women without diabetes, despite the fact that infants of the IDDM women were artificially fed more often and began breastfeeding later than infants in the control group. In addition, the IDDM women were more likely to be delivered by Caesarean section (p < 0.0005), to be delivered earlier (p < 0.0002), and their babies more likely to be admitted to the special care nursery (p < 0.0005).

Download full-text PDF

Source
http://dx.doi.org/10.1177/089033449501100320DOI Listing

Publication Analysis

Top Keywords

women
9
breastfeeding outcomes
8
women insulin
8
insulin dependent
8
dependent diabetes
8
incidence breastfeeding
8
women iddm
8
control group
8
percent iddm
8
percent non-iddm
8

Similar Publications

Background: Transitional-aged youth have a high burden of mental health difficulties in Canada, with Indigenous youth, in particular, experiencing additional circumstances that challenge their well-being. Mobile health (mHealth) approaches hold promise for supporting individuals in areas with less access to services such as Northern Ontario.

Objective: The primary objective of this study is to evaluate the effectiveness of the JoyPop app in increasing emotion regulation skills for Indigenous transitional-aged youth (aged 18-25 years) on a waitlist for mental health services when compared with usual practice (UP).

View Article and Find Full Text PDF

Background: Digital health innovations provide an opportunity to improve access to care, information, and quality of care during the perinatal period, a critical period of health for mothers and infants. However, research to develop perinatal digital health solutions needs to be informed by actual patient and health system needs in order to optimize implementation, adoption, and sustainability.

Objective: Our aim was to co-design a research agenda with defined research priorities that reflected health system realities and patient needs.

View Article and Find Full Text PDF

Background: Opioid medications are important for pain management, but many patients progress to unsafe medication use. With few personalized and accessible behavioral treatment options to reduce potential opioid-related harm, new and innovative patient-centered approaches are urgently needed to fill this gap.

Objective: This study involved the first phase of co-designing a digital brief intervention to reduce the risk of opioid-related harm by investigating the lived experience of chronic noncancer pain (CNCP) in treatment-seeking patients, with a particular focus on opioid therapy experiences.

View Article and Find Full Text PDF

Background: There has been a rise in the popularity of ChatGPT and other chat-based artificial intelligence (AI) apps in medical education. Despite data being available from other parts of the world, there is a significant lack of information on this topic in medical education and research, particularly in Saudi Arabia.

Objective: The primary objective of the study was to examine the familiarity, usage patterns, and attitudes of Alfaisal University medical students toward ChatGPT and other chat-based AI apps in medical education.

View Article and Find Full Text PDF

The growing sophistication of tumor molecular profiling has helped to slowly transition oncologic care toward a more personalized approach in different tumor types, including in bladder cancer. The National Comprehensive Cancer Network recommends that all patients with stage IVA and stage IVB urothelial carcinoma have molecular analysis that integrates at least testing to help facilitate the selection of future therapeutic options. Sequencing of tumor-derived tissue is the mainstay to obtain this genomic testing, but as in other cancers, there has been extensive research into the integration of liquid biopsies in longitudinal management.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!